Compare BLNK & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLNK | SGHT |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.2M | 309.6M |
| IPO Year | 2008 | 2021 |
| Metric | BLNK | SGHT |
|---|---|---|
| Price | $0.54 | $9.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $1.63 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 906.5K | 194.5K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.22 | 28.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $126,197,000.00 | $77,363,000.00 |
| Revenue This Year | N/A | $16.79 |
| Revenue Next Year | $13.70 | $11.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.45 | $3.19 |
| 52 Week High | $2.65 | $9.71 |
| Indicator | BLNK | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 43.23 | 71.67 |
| Support Level | $0.52 | $7.70 |
| Resistance Level | $0.62 | $9.24 |
| Average True Range (ATR) | 0.02 | 0.34 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 21.18 | 74.51 |
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The Blink's principal line of products and services is its Blink EV charging networks, Blink EV charging equipment, and other EV-related services. The Blink Network is a proprietary, cloud-based system that operates, maintains, and manages Blink charging stations and handles the associated charging data, back-end operations, and payment processing. The Blink Network provides fleets, property owners, managers, parking companies, and state and municipal entities, among other types of commercial customers, with cloud-based services.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.